F S&P 500
5,202.50 -10.25 (-0.20%) F Dow Jones
39,140.00 -55.00 (-0.14%) F Nasdaq
18,136.00 -50.50 (-0.28%) E-mini Russell 2000 Index Futur
2,057.60 -7.20 (-0.35%) Petróleo
79.52 +0.53 (+0.67%) Oro
2,316.90 -5.40 (-0.23%)
Sintx Technologies, Inc. (SINT)
Fuera de horario:
Sintx Technologies, Inc.
1885 West 2100 South
Salt Lake City, UT 84119
United States
801 839 3500
https://www.sintx.com
Sector(es): Healthcare
Industria: Medical Devices
Empleados a tiempo completo: 43
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Dr. B. Sonny Bal J.D., M.B.A., M.D., Ph.D. | CEO, President, Principal Financial Officer & Chairman | 460.81k | N/D | 1962 |
| Mr. David Francis O'Brien | Executive VP & COO | 432.46k | N/D | 1965 |
| Mr. Michael Marcroft | Vice President of Sales & Marketing | N/D | N/D | N/D |
| Ms. Gina Moss | Director of Operations | N/D | N/D | N/D |
Descripción
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Gestión corporativa
La calificación ISS Governance QuickScore de Sintx Technologies, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
